Reviva Pharmaceuticals Inc - logo

Reviva Pharmaceuticals Inc - Company & Market Research Reports

Depression and Anxiety Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Depression and Anxiety Disorders Drug Development Pipeline Review, 2018

  • Report
  • 175 Pages
From
Sleep Disorders Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Sleep Disorders Drug Development Pipeline Review, 2017

  • Report
  • 76 Pages
From
Pulmonary Arterial Hypertension (PAH): Drug Development Pipeline Study, H1 2018 - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH): Drug Development Pipeline Study, H1 2018

  • Report
  • 118 Pages
From
Obesity - Pipeline Review, H1 2018 - Product Thumbnail Image

Obesity - Pipeline Review, H1 2018

  • Drug Pipelines
  • 526 Pages
From
Blood Pressure Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Blood Pressure Disorders Drug Development Pipeline Review, 2018

  • Report
  • 213 Pages
From
Obesity - Pipeline Review, H2 2017 - Product Thumbnail Image

Obesity - Pipeline Review, H2 2017

  • Drug Pipelines
  • 518 Pages
From
Schizophrenia - Pipeline Review, H1 2018 - Product Thumbnail Image

Schizophrenia - Pipeline Review, H1 2018

  • Drug Pipelines
  • 334 Pages
From
Global Parkinson's Disease (PD) Drugs Market 2017-2021 - Product Thumbnail Image

Global Parkinson's Disease (PD) Drugs Market 2017-2021

  • Report
  • 85 Pages
From
Depression - Pipeline Review, H2 2018 - Product Thumbnail Image

Depression - Pipeline Review, H2 2018

  • Drug Pipelines
  • 504 Pages
From
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2018 - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 158 Pages
From
Global Central Nervous System Disorders Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Central Nervous System Disorders Therapeutics Market 2016-2020

  • Report
  • 147 Pages
From
Depression - Pipeline Review, H1 2018 - Product Thumbnail Image

Depression - Pipeline Review, H1 2018

  • Drug Pipelines
  • 490 Pages
From
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2018 - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 160 Pages
From
Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2016 - Product Thumbnail Image

Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2016

  • Drug Pipelines
  • 122 Pages
From
Treatment Resistant Depression - Pipeline Insight, 2018 - Product Thumbnail Image

Treatment Resistant Depression - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Psychosis - Pipeline Review, H2 2016 - Product Thumbnail Image

Psychosis - Pipeline Review, H2 2016

  • Drug Pipelines
  • 70 Pages
From
Major Depressive Disorder - Pipeline Review, H2 2016 - Product Thumbnail Image

Major Depressive Disorder - Pipeline Review, H2 2016

  • Drug Pipelines
  • 201 Pages
From
Treatment Resistant Depression - Pipeline Review, H2 2016 - Product Thumbnail Image

Treatment Resistant Depression - Pipeline Review, H2 2016

  • Drug Pipelines
  • 74 Pages
From
5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) - Pipeline Review, H2 2018 - Product Thumbnail Image

5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 63 Pages
From
Autism - Pipeline Review, H2 2018 - Product Thumbnail Image

Autism - Pipeline Review, H2 2018

  • Drug Pipelines
  • 151 Pages
From
Loading Indicator
adroll